Franklin Resources Inc Sarepta Therapeutics, Inc. Transaction History

Franklin Resources Inc

$334 Billion
Q3 2024

A detailed history of Franklin Resources Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 235,187 shares of SRPT stock, worth $29.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

235,187

Previous 235,187 -0.0%

Holding current value

$29.3 Million

Previous $29.4 Million -0.0%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$124.33 - $156.75 $1.05 Million - $1.33 Million	-8,455 Reduced 3.47%	235,187 $29.4 Million
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $1.17 Million - $1.7 Million	10,353 Added 4.44%	243,642 $38.5 Million
Q1 2024 May 13, 2024	BUY	$93.7 - $141.53 $1.78 Million - $2.69 Million	19,023 Added 8.88%	233,289 $30.2 Million
Q4 2023 Feb 09, 2024	SELL	$67.31 - $124.76 $101,099 - $187,389	-1,502 Reduced 0.7%	214,266 $20.7 Million
Q3 2023 Nov 13, 2023	SELL	$102.5 - $123.59 $45,202 - $54,503	-441 Reduced 0.2%	215,768 $26.2 Million
Q2 2023 Aug 11, 2023	BUY	$106.4 - $157.19 $12.1 Million - $17.8 Million	113,308 Added 110.11%	216,209 $24.8 Million
Q1 2023 May 12, 2023	BUY	$117.53 - $155.99 $11.4 Million - $15.1 Million	96,822 Added 1592.73%	102,901 $14.2 Million
Q4 2022 Feb 10, 2023	BUY	$100.86 - $132.13 $24,811 - $32,503	246 Added 4.22%	6,079 $787,000
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $214,335 - $337,568	2,831 Added 94.3%	5,833 $644,000
Q2 2022 Aug 11, 2022	BUY	$62.69 - $88.44 $188,195 - $265,496	3,002 New	3,002 $225,000
Q1 2021 May 13, 2021	SELL	$72.25 - $168.95 $12.3 Million - $28.8 Million	-170,316 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$125.56 - $178.74 $85,129 - $121,185	678 Added 0.4%	170,316 $29 Million
Q3 2020 Nov 12, 2020	BUY	$127.12 - $172.34 $148,094 - $200,776	1,165 Added 0.69%	169,638 $23.8 Million
Q2 2020 Aug 13, 2020	BUY	$93.0 - $171.7 $930 - $1,717	10 Added 0.01%	168,473 $27.7 Million
Q1 2020 May 13, 2020	BUY	$82.38 - $131.64 $5,354 - $8,556	65 Added 0.04%	168,463 $16.5 Million
Q4 2019 Feb 12, 2020	BUY	$76.53 - $135.58 $7,499 - $13,286	98 Added 0.06%	168,398 $21.7 Million
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $30 Million - $64.7 Million	-412,203 Reduced 71.01%	168,300 $12.7 Million
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $15.4 Million - $20.8 Million	-137,102 Reduced 19.11%	580,503 $88.2 Million
Q1 2019 May 14, 2019	BUY	$106.67 - $151.68 $672,021 - $955,584	6,300 Added 0.89%	717,605 $85.5 Million
Q4 2018 Feb 12, 2019	BUY	$97.32 - $148.76 $12.8 Million - $19.6 Million	132,005 Added 22.79%	711,305 $77.6 Million
Q3 2018 Nov 13, 2018	BUY	$115.31 - $161.51 $18.5 Million - $26 Million	160,800 Added 38.42%	579,300 $93.6 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $21.1 Million - $45.2 Million	294,200 Added 236.69%	418,500 $55.3 Million
Q1 2018 May 10, 2018	BUY	$54.02 - $82.27 $6.71 Million - $10.2 Million	124,300 New	124,300 $9.21 Million

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.1M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Sarepta Therapeutics, Inc. Transaction History